360 related articles for article (PubMed ID: 18551095)
1. A review of basic principles of fractals and their application to pharmacokinetics.
Marsh RE; Riauka TA; McQuarrie SA
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):278-88. PubMed ID: 18551095
[TBL] [Abstract][Full Text] [Related]
2. IVIVC of controlled release formulations: physiological-dynamical reasons for their failure.
Dokoumetzidis A; Macheras P
J Control Release; 2008 Jul; 129(2):76-8. PubMed ID: 18538435
[No Abstract] [Full Text] [Related]
3. The concept of fractals in the pharmaceutical sciences.
Koch HP
Pharmazie; 1993 Sep; 48(9):643-59. PubMed ID: 8234397
[TBL] [Abstract][Full Text] [Related]
4. Use of a simulated annealing algorithm to fit compartmental models with an application to fractal pharmacokinetics.
Marsh RE; Riauka TA; McQuarrie SA
J Pharm Pharm Sci; 2007; 10(2):168-79. PubMed ID: 17706176
[TBL] [Abstract][Full Text] [Related]
5. Fractal pharmacokinetics.
Pereira LM
Comput Math Methods Med; 2010 Jun; 11(2):161-84. PubMed ID: 20461596
[TBL] [Abstract][Full Text] [Related]
6. On the ubiquitous presence of fractals and fractal concepts in pharmaceutical sciences: a review.
Pippa N; Dokoumetzidis A; Demetzos C; Macheras P
Int J Pharm; 2013 Nov; 456(2):340-52. PubMed ID: 24025993
[TBL] [Abstract][Full Text] [Related]
7. Multifractality in intracellular enzymatic reactions.
Aranda JS; Salgado E; Muñoz-Diosdado A
J Theor Biol; 2006 May; 240(2):209-17. PubMed ID: 16256143
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in pharmacokinetic modeling.
Ahmad AM
Biopharm Drug Dispos; 2007 Apr; 28(3):135-43. PubMed ID: 17295411
[TBL] [Abstract][Full Text] [Related]
9. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion.
Wang J; Krudy G; Xie XQ; Wu C; Holland G
J Chem Inf Model; 2006; 46(6):2674-83. PubMed ID: 17125207
[TBL] [Abstract][Full Text] [Related]
10. Exploiting QSAR models in lead optimization.
Gedeck P; Lewis RA
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):569-75. PubMed ID: 18600573
[TBL] [Abstract][Full Text] [Related]
11. Image-based chemical screening.
Carpenter AE
Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
[TBL] [Abstract][Full Text] [Related]
12. Basic overview of chemoinformatics.
Engel T
J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169
[TBL] [Abstract][Full Text] [Related]
13. Influence of fractal kinetics on molecular recognition.
Savageau MA
J Mol Recognit; 1993 Dec; 6(4):149-57. PubMed ID: 7917410
[TBL] [Abstract][Full Text] [Related]
14. Modeling fractal-like drug elimination kinetics using an interacting random-walk model.
Marsh RE; Riauka TA
Phys Rev E Stat Nonlin Soft Matter Phys; 2007 Mar; 75(3 Pt 1):031902. PubMed ID: 17500721
[TBL] [Abstract][Full Text] [Related]
15. Use of fractal theory in neuroscience: methods, advantages, and potential problems.
Fernández E; Jelinek HF
Methods; 2001 Aug; 24(4):309-21. PubMed ID: 11465996
[TBL] [Abstract][Full Text] [Related]
16. Scaffold composition and biological relevance of screening libraries.
Shelat AA; Guy RK
Nat Chem Biol; 2007 Aug; 3(8):442-6. PubMed ID: 17637770
[TBL] [Abstract][Full Text] [Related]
17. PK/PD modelling and simulations: utility in drug development.
Rajman I
Drug Discov Today; 2008 Apr; 13(7-8):341-6. PubMed ID: 18405847
[TBL] [Abstract][Full Text] [Related]
18. Role of racemization in optically active drugs development.
Ali I; Gupta VK; Aboul-Enein HY; Singh P; Sharma B
Chirality; 2007 Jun; 19(6):453-63. PubMed ID: 17393472
[TBL] [Abstract][Full Text] [Related]
19. Application of in silico, in vitro and preclinical pharmacokinetic data for the effective and efficient prediction of human pharmacokinetics.
Grime KH; Barton P; McGinnity DF
Mol Pharm; 2013 Apr; 10(4):1191-206. PubMed ID: 23253040
[TBL] [Abstract][Full Text] [Related]
20. Reaction kinetics in intracellular environments with macromolecular crowding: simulations and rate laws.
Schnell S; Turner TE
Prog Biophys Mol Biol; 2004; 85(2-3):235-60. PubMed ID: 15142746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
